Publications by authors named "Declan Flynn"

Claim this Profile
C
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.
Jean G Sathish, Siddhartha Bhatt, Jamie K DaSilva, Declan Flynn, Stephen Jenkinson

Int J Toxicol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis.
Julia De Groot, Dongjun Wu, Declan Flynn, Dylan Robertson, Gary Grant

World J Diabetes· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical power analysis of cardiovascular safety pharmacology studies in conscious rats.
Siddhartha Bhatt, Dingzhou Li, Declan Flynn, Todd Wisialowski, Michelle Hemkens

J Pharmacol Toxicol Methods· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Emily C Cokorinos, Jake Delmore, Allan R Reyes, Bina Albuquerque, Rasmus Kjøbsted, Declan Flynn

Cell Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
Agustin Casimiro-Garcia, Ronald J Heemstra, Christopher F Bigge, Jing Chen, Fred A Ciske, Declan Flynn

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 Agonists.
David W Piotrowski, Kentaro Futatsugi, Joseph S Warmus, Suvi T M Orr, Kevin D Freeman-Cook, Declan A Flynn

ACS Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of companies and drug classes in the 2007-2011 antihypertensive patent literature.
Philip A Carpino, Declan Flynn

Pharm Pat Anal· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
Agustin Casimiro-Garcia, Gary F Filzen, Declan Flynn, Christopher F Bigge, Jing Chen

J Med Chem· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
Michelle Pacholec, John E Bleasdale, Boris Chrunyk, David Cunningham, Declan Flynn

J Biol Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis